Gufic Biosciences Ltd 509079
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 43.67
- Price/Sales
- 4.95
- Dividend Yield (Trailing)
- 0.03%
- Dividend Yield (Forward)
- 0.03%
- Total Yield
- 0.03%
Company Profile
Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare; Criticare Life; Ferticare; Spark; Herbal and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral and a proton-pump inhibitor. It derives maximum revenue from India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 2,671
- Website
- https://www.gufic.com
Comparables
Valuation
|
Metric
|
509079
|
543434
|
532815
|
|---|---|---|---|
Price/Earnings (Normalized) | 43.67 | 34.56 | 52.55 |
Price/Book Value | 7.29 | 5.81 | 5.91 |
Price/Sales | 4.95 | 8.09 | 4.08 |
Price/Cash Flow | 35.27 | 36.48 | 36.20 |
Price/Earnings
509079
543434
532815
Financial Strength
|
Metric
|
509079
|
543434
|
532815
|
|---|---|---|---|
Quick Ratio | 0.89 | 2.47 | 0.86 |
Current Ratio | 1.61 | 5.17 | 1.61 |
Interest Coverage | 8.56 | 51.09 | 4.55 |
Quick Ratio
509079
543434
532815
Profitability
|
Metric
|
509079
|
543434
|
532815
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
509079
543434
532815
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Wdzjzgbzx | Khctt | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Vnyzztbkp | Rmnddv | $77.4 Bil | |||
| Haleon PLC ADR
HLN
| Trxlltgg | Mgyk | $47.3 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Vkxcbmg | Mzgt | $19.0 Bil | |||
| Viatris Inc
VTRS
| Pthvgnlf | Ftbgr | $13.9 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Yrvvxytk | Hkpm | $13.4 Bil | |||
| Catalent Inc
CTLT
| Lqggdms | Fxdtv | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Plldcyfh | Jbhyt | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Pwdhhwj | Wxndb | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Bhzfvwwh | Dllz | $2.5 Bil |
United States